Proteomic Profiling of Gastric Cancer in Serum Using Magnetic Bead Based Sample Fractionation and MALDI-TOF-MS

Chinese Journal of Clinical Oncology

Volumn 37, Issue 16, 2010, Pages 933-936

  Gao, Xiang ^a   Liu, Wentao ^a   Yang, Qiumeng ^a   Liu, Bingya ^b   Cai, Li ^b   Li, Jianfang ^b   Zhu, Zhenglun ^b   Xiang, Ming ^a   Yan, Min ^a   Zhu, Zhenggang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Shanghai Institute of Digestive Surgery   (China)

Author keywords

Cancer biomarkers; ClinProTool; Data mining; Gastric cancer; Magnetic beads

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; CANCER SCREENING; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DATA MINING; HUMAN; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PROTEOMICS; SENSITIVITY AND SPECIFICITY; SERUM; STOMACH CANCER; VOLUNTEER;

EID: 77956586931     PISSN: 16727118     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1000-8179.2010.16.011     Document Type: Article

References (14)

1. Ucar E, Semerci E, Ustun H, et al. Prognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in gastric cancer[J]. Adv Ther, 2008,25(10):1075-1084.
2. Liu W, Liu B, Xin L, et al. Down-regulated expression of complement factor I: a potential suppressive protein for gastric cancer identified by serum proteome analysis[J]. Clin Chim Acta, 2007,377(1-2):119-126. (Pubitemid 44908239)
3. Hao Y, Yu Y, Wang L, et al. IPO-38 is identified as a novel serum biomarker of gastric cancer based on clinical proteomics technology [J]. J Proteome Res, 2008,7(9):3668-3677.
4. Bichsel VE, Liotta LA, Petricoin EF 3rd. Cancer proteomics: from biomarker discovery to signal pathway profiling[J]. Cancer J, 2001,7(1):69-78.
5. Von Eggeling F, Junker K, Fiedler W, et al. Mass spectrometry meets chip technology: a new proteomic tool in cancer research[J]? Electrophoresis, 2001,22(14):2898-2902.
6. Leung SM, Pitts RL. A novel approach using MALDI-TOF/TOF mass spectrometry and prestructured sample supports (Anchor-Chip Technology) for proteomic profiling and protein identification [J]. Methods Mol Biol, 2008,441:57-70.
7. Ketterlinus R, Hsieh SY, Teng SH, et al. Fishing for biomarkers: analyzing mass spectrometry data with the new ClinProTools software [J]. Biotechniques, 2005, Suppl: 37-40.
8. Kojima K, Asmellash S, Klug CA, et al. Applying proteomic-based biomarker tools for the accurate diagnosis of pancreatic cancer[J]. J Gastrointest Surg, 2008,12(10):1683-1690.
9. Dekker LJ, Boogerd W, Stockhammer G, et al. MALDI-TOF mass spectrometry analysis of cerebrospinal fluid tryptic peptide profiles to diagnose leptomeningeal metastases in patients with breast cancer [J]. Mol Cell Proteomics, 2005,4(9):1341-1349.
10. Ebert MP, Niemeyer D, Deininger SO, et al. Identification and confirmation of increased fibrinopeptide a serum protein levels in gastric cancer sera by magnet bead assisted MALDI-TOF mass spectrometry[J]. J Proteome Res, 2006,5(9):2152-2158. (Pubitemid 44330807)
11. Schuerenberg M, Luebbert C, Eickhoff H, et al. Prestructured MALDI-MS sample supports[J]. Anal Chem, 2000,72(15):3436-3442.